For press inquiries click here to contact us.
Endpoints
The biotech IPO party rocks on with $120M raise for I/O player Arcus Biosciences
FierceBiotech
Qiagen pays $40M to work with Natera on prenatal screening tests
Endpoints
MyoKardia steps closer to the launch of a groundbreaking heart trial after finding its low-dose starting point
Good Morning America
What to Know About the New Affordable BRCA Gene Test
FierceBiotech
Inscripta bags $55M+ to push forward full CRISPR suite
FierceBiotech
Arcus Biosciences eyes $100M IPO
CNBC
Aimmune’s peanut allergy drug meets main goal, shares surge
Fast Company
Color Genomics named to the World’s Most Innovative Companies 2018
FierceBiotech
DNAnexus’ new solution integrates next-generation sequencing data in clinical trials
Please see important disclaimers in the Terms section.
